Page last updated: 2024-11-06

4-cyanobenzaldehyde

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

4-Cyanobenzaldehyde is an important organic compound used as a building block in the synthesis of various organic compounds. It is synthesized through a multi-step process that typically involves the nitration of toluene, followed by reduction to the corresponding amine, and then finally oxidation to the aldehyde. 4-cyanobenzaldehyde is a versatile building block in organic synthesis and has been used in the preparation of various pharmaceuticals, agrochemicals, and other fine chemicals. It is also a key intermediate in the synthesis of various liquid crystals and other materials with interesting optical properties. Studies on 4-cyanobenzaldehyde focus on its reactivity, its use in the synthesis of new and interesting molecules, and its potential applications in different fields. 4-cyanobenzaldehyde has been studied for its potential use in the synthesis of new materials with enhanced properties. For example, 4-cyanobenzaldehyde has been used to synthesize new liquid crystals with improved properties.'

Cross-References

ID SourceID
PubMed CID66042
CHEMBL ID1922276
CHEBI ID156308
SCHEMBL ID7047
MeSH IDM0470449

Synonyms (50)

Synonym
AC-283
EN300-20402
BB 0260077
nsc5091
wln: vhr dcn
p-formylbenzonitrile
nsc-5091
4-cyanobenzaldehyde ,
benzonitrile, p-formyl-
benzonitrile, 4-formyl-
usaf kf-1
benzaldehyde, p-cyano-
p-cyanobenzaldehyde
105-07-7
4-formylbenzonitrile
terephthalaldehydonitrile
einecs 203-267-3
nsc 5091
p-cyanobenzenecarboxaldehyde
benzaldehyde,4-cyano mfc8 h5 n1 o1
inchi=1/c8h5no/c9-5-7-1-3-8(6-10)4-2-7/h1-4,6
4-formylbenzonitrile, 95%
STK501695
CHEBI:156308
AKOS000119506
4-methanoylbenzenecarbonitrile
A801147
4-formyl-benzonitrile
dwh62y9tca ,
unii-dwh62y9tca
CHEMBL1922276 ,
bdbm50358749
BP-11467
FT-0601275
AM20060796
SCHEMBL7047
PS-5292
4-cyano benzaldehyde
4-cyano-benzaldehyde
p-cyano benzaldehyde
4-formyl benzonitrile
4-cyanobenzal-dehyde
DTXSID6059312
J-650097
STR00719
W-108795
mfcd00003376
CS-W001948
F0001-0136
Z104478052

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Inhibitors 51 and 54 demonstrated oral bioavailability in a rat PK study."( Discovery of novel sphingosine kinase-1 inhibitors. Part 2.
Asmussen, G; Booker, M; Fitzgerald, M; Hirth, B; Kane, JL; Klaus, C; Liao, J; Noson, KD; Xiang, Y; Yee, C, 2010
)
0.36
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
benzaldehydesAny arenecarbaldehyde that consists of a formyl substituted benzene ring and its substituted derivatives thereof.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID632143Inhibition of CYP2A6 in human liver microsomes assessed as inhibition of coumarin 7-hydroxylation after 10 mins by plate reader2011Bioorganic & medicinal chemistry, Dec-01, Volume: 19, Issue:23
Identification of novel CYP2A6 inhibitors by virtual screening.
AID1544945Inhibition of NO711 binding to mouse GAT1 expressed in HEK293 cell membranes assessed as residual binding at 1 uM incubated for 4 hrs in presence of NO711 by LC-ESI-MS/MS analysis relative to control2019Bioorganic & medicinal chemistry, 07-01, Volume: 27, Issue:13
Application of the concept of oxime library screening by mass spectrometry (MS) binding assays to pyrrolidine-3-carboxylic acid derivatives as potential inhibitors of γ-aminobutyric acid transporter 1 (GAT1).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.49

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.49 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index42.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.49)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]